Chemotherapeutic trials on human malignant astrocytomas in organ culture.
A technique of organ culture based on a three-dimensional porous matrix was employed for chemotherapeutic trials on human malignant astrocytomas. The method allows neoplasms to retain the morphological identity and the histological characteristics they possess in vivo. Success in culture was greatest with high-grade astrocytomas, the majority of which showed definite infiltration of the matrix. Low-grade tumors, if viable, did not display active penetration. Drug trials on eight malignant astrocytomas included BCNU, methyl CCNU, VP 16-213, and Solu-Medrol. Cyanide and luciferase were used as experimental metabolic toxins. Evidence of cytotoxicity was assesed qualitatively by histological changes on microscopic preparations of treated and control cultures. Microfluorometric determinations of reduced nicotinamide adenine dinucleotide (NADH) were applied to these trials in an effort to detect a quantitative biochemical index of drug effects. A variable rise in although correlation with microscopic changes was inconsistent. Because of its potential merits, organ culture may be a valuable tool for further work on pharmacological management of malignant gliomas.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001254:Astrocytoma / Q000188:drug therapy* / Q000378:metabolism; D002330:Carmustine / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D003486:Cyanides / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D008130:Lomustine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008156:Luciferases / Q000494:pharmacology; D008775:Methylprednisolone / Q000627:therapeutic use; D009243:NAD / Q000378:metabolism; D009924:Organ Culture Techniques
D000970:Antineoplastic Agents; D003486:Cyanides; D009243:NAD; D005047:Etoposide; D008130:Lomustine; D008156:Luciferases; D002330:Carmustine; D008775:Methylprednisolone